GRCU Company info 08/18/2014 03:22:53 $GRCU We can not let

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
GRCU Company info 08/18/2014 03:22:53 $GRCU
We can not let this all fakes longs play the game again!! Let them burn!! $ GRCU to da moon !!
Agreed many will be chasing big time soon times imho.

#GRCU
Notice that suddenly fake long predict next week or more gonna be bad,cause they all sold their position and being greedy with trying to load cheapies !! Don't play with fire you will get burned !! Long $ GRCU
So many fake longs here !! I hope this going up next week so they will learn to be patient !!
Really funny !! If it does going up you need to buy higher !! Lol!!
Come on !! You sold your share and now you predict is gonna down so you can load again !! We been down so long cause some long or almost all sell their share ,I don't think we gonna down any more !! Shame that you called your self long
I get a kick out of shareholders giving PPS predictions without reasons one way or the other or adding an "IMO" to the post. I'm a known long and I've been around since January. Here are my PPS thoughts without the technical analysis but some basic observations. The historical chart below shows the PPS sticking around the .02s, .03s, and .04s from 4/21 thru 6/3. Look at the list of PR's below within that 7 week timeline. IMO the PPS levels within that short 7 week timeline were based on Calkins assignment as CEO and the combined experience of the other BOD members. It was also based on the exuberance of the allbotanical website opening, name/symbol change, share reduction, dividend(didn't happen), CBD capsules coming, etc. The PPS didn't move up because hundreds of prospective shareholders read "all pages of greatly improved financials" because the financials were TTDZ related. The PPS didn't move up on increased sales because sales were just getting started or non-existent! The PPS was driven by speculation, hope, and buying volume by "longs" still here today.
Then after 6/3 schools let out and vacations started and IMO summertime volume hit, some shareholders bailed for the summer, flippers showed up, GRCU volume dried up, and MM manipulation took advantage of all. Labor day is two weeks away so trading season and volume is coming back. Volume started picking up on Friday albeit still relatively low and volume precedes price. I've gone back and forth about this with some and I agree that fluff PR's are a mistake. On the other hand if Calkin is ready to release other PR's with progress on previously announced milestones or has news on new business developments then we could start moving up immediately. If the 2ndQ financials and cbdoil.com website are to stand on their own merits without a PR and then the only ones who will be familiar with recent developments will be those who read this or other boards. Media outlets will remain silent! If that's the case then GRCU could trade sideways for weeks until the sector propaganda starts and over-exuberance kick starts again and more eyes seeking MJ/MMJ investments in general come to GRCU. In any case there are many "ifs, ands, and buts"! All in my opinion!


I like your way of thinking bro. Agree 100% with you! CALKIN is the EINSTEIN of MEDICAL MARIJUANA $$$$

#GRCU
Calkin is Einstein. E = mc2. Economics = More Cash 2 you and I.
http://inlandempire.craigslist.org/bfs/4554700882.html
Calkin is the baker and the dough will rise. Do not doubt Calkin he is not a butcher.
Gotta love posts starting with "IMAGINE IF"




/sarcasm
Now that is good math and economics!!!
sounds about right.
Where did you learn math from ? University of Trailer Park ? You cannot at the end of each year change the base price ! It is fixed at $0.0115 because you are buying at today's price of $0.0115 and not selling. Think man think.
Proof is in the puddin and the cream will rise to the top. Do not fear the evil GRCU is the cream of the crop!
Quote:

So the insiders will make all of the decisions - as shareholders are locked out.

Management is underwhelming at the very least.

Quote:
So where is the third party lab analysis?

The point is no one knows where these capsules were made - the origin of the hemp oil - the conditions of where the capsules were manufactured.

You are putting blinders on once again and believing everything the company says - it was a bad experience last time.

GRCU is pink limited that has deregistered the stock and the TA is gagged - all the signs of a share selling scheme.

I can't wait until the next financial report.


.0115 X 3 = .0345 year 1
.0345 X 3 = .1035 year 2
.1035 X 3 = .3105 year 3
.3105 X 3 = .9315 year 4
.9315 X 3 = $2.7945 year 5
I do not believe my math is wrong. Look at a price of $2 in 5 years from now that is a return of 2/0.0115 = 173 bags. Since that is over 5 years then 173/5 = 34.7 bags per year and NOT 3 bags per year.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Peptide Therapy Rules Change: Gameday Ups the Ante

Updated Category News Views 110

Gameday Men's Health: Leading the Safe Peptide Charge Finally, we got some regulatory sanity stepping up to the plate with peptides. You see, the FDA's new interim policy is letting state-licensed compounding pharmacies work their magic with peptides, but only under strict medical watch. And Gameday Men's Health sure ain't wasting any time setting up shop in this fresh...

Continue Reading
Fidelis Care Opens $120K Workforce Grants for Aid

Updated Category News Views 112

Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...

Continue Reading
Chip Earnings Fuel Market Gains Amid Volatility Dip

Updated Category News Views 56

Tech Earnings Drive Market Resilience Amid a climate of economic uncertainty, it's refreshing to see semiconductor and tech earnings offering a little backbone to the market. This week, the S&P 500 climbed 1.51%, while the Nasdaq Composite jumped 1.98% over three sessions. It's like watching Rocky get up off the mat—those indices pushing higher when it seemed like they...

Continue Reading
Read/Write Labs Tackles Brain-Tech Fusion Ambitions

Updated Category News Views 88

Buck up, investors! There's a new player on the field marrying AI and neuroscience with some serious firepower and a respectable roster. Read/Write Labs—what you might've known yesterday as Dandelion Science—has kicked off under a fresh banner, amping up efforts to decode and recode our noggin's electrical orchestra. And with the likes of Jim DiCarlo, Dan Yamins, and...

Continue Reading
Fannie Mae Q3 2026 Earnings Surpass Expectations

Updated Category News Views 84

An Upward Trend in Fannie Mae's Financials Hold onto your hats—Fannie Mae's swinging into action with hefty third-quarter numbers that'd make most firms drool. The latest figures, disclosed in their 10-Q filing, boast a net income of $4.2 billion for Q3 2026. You heard me right, billion! Now, to a market vet, these aren't digits to scoff at. And as the economy keeps...

Continue Reading
Aktia Bank: Steady Ratings, Focused Expansion in Europe

Updated Category News Views 123

Aktia's Ratings Get a Boost In the world of financial minutiae, it was S&P Global Ratings that took the stage, buzzing about Aktia Bank Plc. The bank just had its ratings held steady with an outlook lift from negative to stable. That's like someone throwing you a life jacket when you're treading water; significant if you're trying to stay afloat, not so much if you've got...

Continue Reading
ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

Updated Category News Views 38

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Continue Reading
VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 45

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Ballard’s HPU Agile-H Poised to Transform Portable Energy

Updated Category News Views 76

Another Step Forward with Hydrogen Ballard's got another ace up its sleeve with the HPU Agile-H. Now here’s the kicker—everyone’s scrambling for cleaner, more portable energy solutions, and Ballard’s stepped up. Born from their acquisition of GeoPura, this lightweight hydrogen powerhouse is engineered for those spots rudely ignored by the grid. Place your bets on...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading

Top 5 Most Recently Viewed Articles

Sollis Health Welcomes Katy Marshall as Chief Growth Officer

Updated Category News Views 511

Sollis Health Welcomes Katy Marshall as Chief Growth Officer The leading concierge medical provider has appointed Katy Marshall as Chief Growth Officer. With her extensive background in driving growth for consumer and healthcare brands, she will guide the company's marketing, sales, and product strategies. Experienced Leadership Katy brings a wealth of experience to...

Continue Reading
Kulicke & Soffa Delivers Strong Q4 Performance Highlights

Updated Category News Views 153

Strong Financial Performance in Q4 Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) reported impressive financial results for the fourth quarter, showcasing resilience and growth in a challenging market. The company achieved a net revenue of $177.6 million, reflecting its ongoing commitment to innovation and operational efficiency. Lester Wong, the Interim Chief...

Continue Reading
Unlocking Dividend Income: Strategies for Salesforce Investors

Updated Category News Views 85

Understanding Salesforce's Dividend Potential Salesforce, Inc. (NYSE: CRM) is a leading company known for its innovative cloud-based solutions. With its upcoming fourth-quarter financial results, many investors are curious about how to maximize their returns, particularly through dividends. This approach can be an excellent way to create a significant income stream while...

Continue Reading
Investigation Launched into Sage Therapeutics' Recent Drug Trials

Updated Category News Views 93

Introducing Sage Therapeutics Sage Therapeutics, Inc. (NASDAQ: SAGE) is a biopharmaceutical company dedicated to developing innovative therapies aimed at enhancing brain health. However, recent events have raised serious concerns among investors, prompting an investigation into possible violations of federal securities laws. Stock Price Affected by Recent Events FDA...

Continue Reading
Genius Group Investors Can Pursue Class Action for Losses

Updated Category News Views 208

Genius Group Limited Faces Class Action Lawsuit Genius Group Limited, recognized by its ticker symbol GNUS, is currently embroiled in a class action lawsuit aimed at addressing significant investor losses. This legal action comes as a response to alleged stock market misconduct by certain trading firms. Investors Encouraged to Take Action The law firm Bronstein, Gewirtz &...

Continue Reading